Updated Jul 16, 2026
Schmid John P. has filed 7 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $1.16M.

| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | TRAX | First Tracks Biotherapeutics, Inc. | M — Option exercise | 6.0K | $0.00 | |
| 2026-06-17 | ANAB | ANAPTYSBIO, INC | M — Option exercise | 6.0K | $0.00 | |
| 2026-04-02 | ANAB | ANAPTYSBIO, INC | S — Open-market sale | 522 | $57.40 | $30K |
| 2026-04-02 | ANAB | ANAPTYSBIO, INC | S — Open-market sale | 7.5K | $56.70 | $427K |
| 2026-04-02 | ANAB | ANAPTYSBIO, INC | S — Open-market sale | 12.6K | $55.71 | $702K |
| 2025-08-11 | BBOT | BridgeBio Oncology Therapeutics, Inc. | M — Option exercise | 30.0K | — |
Schmid John P. is a corporate insider — currently tracked as Insider of First Tracks Biotherapeutics, Inc. (TRAX). InsiderAlpha tracks every SEC Form 4 filing in real time.
7 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.16M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Schmid John P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.